Delivery Order SPE2DB22D3011-SPE2DB24FQ0NN
Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,132.71 Firm Fixed Price Delivery Order covers the supply of Zonisade 100 mg/5 ml oral suspension in 150 ml bottles, with a performance period through May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zonisade 100 mg/5 ml oral suspension, a pharmaceutical product. The contract has a firm fixed price of $12,926.55 and a period of performance through April 22, 2025. This contract is not set-aside and was awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,097.28 by the Defense Logistics Agency on September 8, 2025, for the supply of Zonisade 100 mg/5 mL oral suspension in a 150 mL container. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.70 to AmerisourceBergen Drug Corp for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The contract was competitively awarded with no...
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,122.49 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a delivery order valued at $889.12 to Amerisourcebergen Drug Corp for the supply of 150ml bottles of the pharmaceutical product Zonisade 100mg/5ml oral suspension. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified medication to the Defense Logistics Agency from its facility located in Conshohocken, Pennsylvania under a firm fixed price contract scheduled to be completed by August 16, 2023. The parent company of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The award, valued at $2,512.71, was made by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is September 30, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major...